Table 1. RPTPα mutants observed in human tumour samples.
Mutant | Occurrence | Splicing error | Protein mutation | Deleted catalytic regions |
---|---|---|---|---|
RPTPα245 | 1/9 Breast | New cryptic exon within | Δ(238–793); +8 spurious | D1, D2 |
2/8 Colon | CDS introns 5–6 | COOH amino acids | ||
1/2 Liver | ||||
0/7 Lung | ||||
0/10 Thyroid | ||||
RPTPα445 | 0/9 Breast | Deleted CDS exons 10–12; | Δ(339–479); Δ(561–793); | D1, D2 |
1/8 Colon | CDS introns 14–15 not excised | +26 spurious COOH amino acids | ||
0/2 Liver | ||||
0/7 Lung | ||||
0/10 Thyroid | ||||
RPTPα652 | 1/9 Breast | Deleted CDS exons 10–12 | Δ(339–479) | D1 |
0/8 Colon | ||||
0/2 Liver | ||||
0/7 Lung | ||||
0/10 Thyroid | ||||
Exons and introns are numbered according to the wt RPTPα short isoform sequence starting with 1 at the first coding sequence exon (this is exon 4 in Vega transcript PTPRA-001 and exon 5 in PTPRA-002). Protein sequences are numbered according to the wt sequence starting with 1 at the N-terminal Met. CDS: coding sequence. |